{
    "clinical_study": {
        "@rank": "45316", 
        "arm_group": [
            {
                "arm_group_label": "Phenylephrine", 
                "arm_group_type": "Active Comparator", 
                "description": "Phenylephrine for maintaining blood pressure within 10 % of baseline"
            }, 
            {
                "arm_group_label": "Ephedrine", 
                "arm_group_type": "Active Comparator", 
                "description": "Ephedrine for maintaining blood pressure within 10 % of baseline"
            }
        ], 
        "brief_summary": {
            "textblock": "Phenylephrine administration is associated with reductions in CO and SctO2 compared with\n      ephedrine when used for blood pressure management in women with pre-eclampsia undergoing\n      cesarean delivery under spinal anesthesia."
        }, 
        "brief_title": "Phenylephrine Versus Ephedrine in Pre-eclampsia", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Pre-eclampsia", 
        "condition_browse": {
            "mesh_term": [
                "Eclampsia", 
                "Pre-Eclampsia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  English speaking\n\n          -  Age \u226518 yrs\n\n          -  Pre-eclampsia (mild, or severe)\n\n          -  Non-laboring women\n\n          -  CD under spinal anesthesia\n\n        Exclusion Criteria:\n\n          -  Height < 5'0\"\n\n          -  Allergy to phenylephrine or ephedrine, or any other standardized medication\n\n          -  Severe Cardiac disease in pregnancy with marked functional limitations (NYHA Class\n             III and IV)\n\n          -  Patients on Monoamine Oxidase Inhibitors or Tricyclic Antidepressants\n\n          -  History of recent amphetamine or cocaine use.\n\n          -  Subject enrollment in another study involving a study medication within 30 days of CD\n\n          -  Any other physical or psychiatric condition which may impair their ability to\n             cooperate with study data collection"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02025426", 
            "org_study_id": "Pro00032812"
        }, 
        "intervention": [
            {
                "arm_group_label": "Phenylephrine", 
                "intervention_name": "Phenylephrine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Ephedrine", 
                "intervention_name": "Ephedrine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ephedrine", 
                "Phenylephrine", 
                "Oxymetazoline", 
                "Pseudoephedrine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Cesarean delivery", 
            "Spinal Anesthesia"
        ], 
        "lastchanged_date": "December 30, 2013", 
        "location": {
            "contact": {
                "email": "habib001@mc.duke.edu", 
                "last_name": "Ashraf S Habib, MD", 
                "phone": "919-668-6266"
            }, 
            "facility": {
                "address": {
                    "city": "Durham", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27705"
                }, 
                "name": "Duke University Medical Center"
            }, 
            "investigator": {
                "last_name": "Ashraf S Habib, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Impact of Vasopressor Administration on Maternal and Neonatal Outcomes in Women With Pre-eclampsia", 
        "other_outcome": [
            {
                "measure": "Changes in umbilical artery pulsatility index measured by ultrasound following initiation of spinal anesthesia", 
                "safety_issue": "No", 
                "time_frame": "Intraoperative from spinal placement till 10 min after spinal"
            }, 
            {
                "measure": "Neonatal umbilical cord gases and lactates", 
                "safety_issue": "No", 
                "time_frame": "Within 5 minutes after delivery"
            }, 
            {
                "measure": "Intraoperative hypotension", 
                "safety_issue": "No", 
                "time_frame": "Intraoperatively from spinal placement till 10 minutes after delivery"
            }, 
            {
                "measure": "Intraoperative nausea and vomiting", 
                "safety_issue": "No", 
                "time_frame": "Intraoperatively from time of spinal placement until end of surgery."
            }, 
            {
                "measure": "Changes in uterine artery pulsatility index measured by ultrasound following initiation of spinal anesthesia", 
                "safety_issue": "No", 
                "time_frame": "Intraoperatively from spinal placement to 10 min after spinal"
            }
        ], 
        "overall_contact": {
            "email": "habib001@mc.duke.edu", 
            "last_name": "Ashraf S Habib, MD", 
            "phone": "919-668-6266"
        }, 
        "overall_official": {
            "affiliation": "Duke University", 
            "last_name": "Ashraf S Habib, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Cerebral tissue oxygen saturation", 
            "safety_issue": "No", 
            "time_frame": "Intraoperative from spinal placement till 10 min after delivery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02025426"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Cardiac output", 
            "safety_issue": "No", 
            "time_frame": "Intraoperative from spinal placement till 10 min after delivery"
        }, 
        "source": "Duke University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Duke University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}